Trepibutone

{{Short description|Chemical compound}}

{{Infobox drug

| IUPAC_name = 4-Oxo-4-(2,4,5-triethoxyphenyl)butanoic acid

| image = Trepibutone.png

| image_class = skin-invert-image

| tradename =

| Drugs.com = {{drugs.com|international|trepibutone}}

| pregnancy_AU =

| pregnancy_US =

| pregnancy_category =

| legal_AU =

| legal_CA =

| legal_UK =

| legal_US =

| legal_status =

| routes_of_administration =

| bioavailability =

| protein_bound =

| metabolism =

| elimination_half-life =

| excretion =

| CAS_number = 41826-92-0

| ATC_prefix = A03

| ATC_suffix = AX09

| PubChem = 5536

| DrugBank =

| ChemSpiderID = 5335

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = H1187LU49Q

| C=16 | H=22 | O=6

}}

Trepibutone is a drug used for functional gastrointestinal disorders.{{Cite web|url=https://pubchem.ncbi.nlm.nih.gov/compound/5536|title=Trepibutone| work = PubChem | publisher = U.S. National Library of Medicine |language=en|access-date=2019-03-01}} Trepibutone promotes secretion of the bile and pancreatic juice, and accelerates flaccidity of the smooth muscle in the gastrointestinal tract to lower internal pressure of the gallbladder and bile duct. It improves the symptoms of the bile duct and pancreatic disease. It is usually used for improvement of cramp and bile secretion associated with cholelithiasis, cholecystitis, cholangitis, dyskinesia of the biliary tract or postcholecystectomy syndrome, or pain and gastrointestinal symptoms associated with chronic pancreatitis.{{Cite web|url=https://drugs.ncats.io/drug/H1187LU49Q|work = NCATS Inxight: Drugs | title = Trepibutone | publisher = National Center for Advancing Translational Sciences (NCATS) |language=en|access-date=2019-03-01}}